Inactivation of human immunodeficiency virus by betadine products and chlorhexidine

Journal of Acquired Immune Deficiency Syndromes

Volumn 2, Issue 1, 1989, Pages 16-20

  Harbison, Mary A ^a   Hammer, Scott M ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; POVIDONE IODINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL CULTURE; CYTOTOXICITY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN;

CLINICAL RESEARCH; DISEASES; ECONOMIC FACTORS; EXAMINATIONS AND DIAGNOSES; HIV INFECTIONS--PREVENTION AND CONTROL; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; RESEARCH AND DEVELOPMENT; RESEARCH METHODOLOGY; TECHNOLOGY; TREATMENT; VIRAL DISEASES;

CHLORHEXIDINE; HIV; POVIDONE; POVIDONE-IODINE; RNA-DIRECTED DNA POLYMERASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024539049     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Spire B, Barré-Sinoussi F, Montagnier L, Chermann JC. Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet 1984; 1:899-901.
2. Martin LS, McDougal JS, Loskoski SL. Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virus. J Infect Dis 1985; 152:400-3.
3. Kaplan JC, Crawford DC, Durno AG, Schooley RT. Inactivation of human immunodeficiency virus by Betadine. Infect Control 1987; 8:412-4.
4. Asanaka M, Kurimura T. Inactivation of human immunodeficiency virus (HIV) by povidone-iodine. Yonago Acta Med 1987; 30:89-92.